clinical-application

Stereotactic Body Radiotherapy (SBRT)

Hypofractionated ablative radiation therapy — delivers very high dose per fraction (typically 6–20 Gy) in a small number of fractions (1–5) to well-localized extracranial tumors. Principal applications: early-stage non-small-cell lung cancer, liver metastases, prostate cancer, spine metastases, oligometastatic disease, pancreatic cancer (emerging).

SBRT's clinical success depends on submillimeter spatial accuracy + motion management. A 3 mm error at 10 Gy × 5 fractions is meaningfully different from the same error at 2 Gy × 30 fractions — the dose gradient around an SBRT target is steep.

Workflow

  1. Simulation — CT simulation scan with 4DCT for moving targets. Contrast-enhanced when indicated; fusion with MRI / PET for contouring.
  2. Contouring — physician + physicist define GTV, CTV, ITV (for motion), PTV margins + OARs (organs at risk).
  3. Planning — VMAT or IMRT plan optimization; dose constraints per TG-101 or institutional guidelines.
  4. Plan QA — physicist-signed; patient-specific QA (ArcCHECK, MapCheck, portal dosimetry).
  5. Delivery — daily CBCT IGRT before each fraction; motion management (gating, breath-hold, tracking) as appropriate.

Typical systems

Motion management options

Clinical characteristics

Related